✦ LIBER ✦

Methotrexate and aminopterin exhibit similar in vitro and in vivo preclinical activity against acute lymphoblastic leukaemia and lymphoma

✍ Scribed by Min H. Kang; Narine Harutyunyan; Connor P. Hall; Rachael A. Papa; Richard B. Lock

Book ID: 108676237
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 241 KB
Volume: 145
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2009.07631.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Gemtuzumab ozogamicin (Mylotarg) has the

Gemtuzumab ozogamicin (Mylotarg) has therapeutic activity against CD33+ acute lymphoblastic leukaemias in vitro and in vivo

✍ J. Golay; N. Di Gaetano; D. Amico; E. Cittera; A. M. Barbui; R. Giavazzi; A. Bio 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB

Association of genetic polymorphism in t

Association of genetic polymorphism in the folate metabolic pathway with methotrexate pharmacokinetics and toxicity in childhood acute lymphoblastic leukaemia and malignant lymphoma

✍ Barbara Faganel Kotnik; Iztok Grabnar; Petra Bohanec Grabar; Vita Dolžan; Janez 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 264 KB

Chimeric, divalent and tetravalent anti-

Chimeric, divalent and tetravalent anti-CD19 monoclonal antibodies with potent in vitro and in vivo antitumor activity against human B-cell lymphoma and pre-B acute lymphoblastic leukemia cell lines

✍ Xiao-Yun Liu; Laurentiu M. Pop; Lydia Tsai; Iliodora V. Pop; Ellen S. Vitetta 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 295 KB

## Abstract CD19 is an attractive therapeutic target for treating human B‐cell tumors. In our study, chimeric (c) divalent (cHD37) and tetravalent (cHD37‐DcVV) anti‐CD19 monoclonal antibodies (MAbs) were constructed, expressed and evaluated for their binding to human 19‐positive (CD19^+^) tumor cel

Novel pyrrolo-1,5-benzoxazepine compound

Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo

✍ Bright, S A; McElligott, A M; O'Connell, J W; O'Connor, L; Carroll, P; Campiani, 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 483 KB

Fully human antibody exhibits pan-human

Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas

✍ Tomonori Tawara; Kazumasa Hasegawa; Yusuke Sugiura; Tomoyuki Tahara; Isao Ishida 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

Genetic variation of in vitro cytolytic

Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line

✍ Rolf Kiessling; Gyözö Petranyi; George Klein; Hans Wigzell 📂 Article 📅 1975 🏛 John Wiley and Sons 🌐 French ⚖ 513 KB

## Abstract Spleens of normal young mice of certain genotypes contain lymphocytes that can kill strain A‐derived YAC‐1 and some other __in vitro__‐grown Moloney lymphoma lines in a ^51^Cr‐release cytotoxic test. We have previously shown that mouse strains can be classified as high or low reactors i